The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates
- PMID: 14651605
- DOI: 10.1046/j.1350-1925.2003.00441.x
The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates
Abstract
The 'Rome' criteria for irritable bowel syndrome (IBS) have evolved over 15 years with four published versions. The impact of these changes on community prevalence rates is not known. Study aims were to estimate the prevalence of IBS using the four Rome criteria and agreement between Rome II and previous criteria. Questionnaires were mailed to a random sample of Olmsted County, Minnesota residents in 1992. Age- and gender-adjusted prevalence estimates were calculated for Rome II (1999), Rome I (1992), Rome (1990), and Rome (1989) criteria. Per cent agreement and kappa values were calculated to assess agreement. Of 892 eligible subjects, 643 (72%) responded. The age- and gender-adjusted prevalence of IBS was 5.1% [95% confidence interval (CI): 3.1, 7.0], 6.8% (95% CI: 4.7, 8.9), 5.1% (95% CI: 3.2, 7.1) and 27.6% (95% CI: 23.6, 31.5), respectively. In comparison with Rome II criteria, per cent agreement and kappa values were 97.2% and 0.78 (95% CI: 0.69, 0.88), 96.4% and 0.68 (95% CI: 0.55, 0.80), and 79.0% and 0.29 (95% CI: 0.19, 0.40), respectively. Thus, although differences were seen with the older criteria, compared with the Rome I criteria, good agreement was seen and community prevalence estimates were similar with the Rome II criteria.
Similar articles
-
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome.Am J Gastroenterol. 2000 Oct;95(10):2816-24. doi: 10.1111/j.1572-0241.2000.03192.x. Am J Gastroenterol. 2000. PMID: 11051354
-
Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.J Gastroenterol Hepatol. 2006 Nov;21(11):1687-92. doi: 10.1111/j.1440-1746.2006.04269.x. J Gastroenterol Hepatol. 2006. PMID: 16984590
-
Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.Aliment Pharmacol Ther. 2004 Aug 1;20(3):339-45. doi: 10.1111/j.1365-2036.2004.02034.x. Aliment Pharmacol Ther. 2004. PMID: 15274671
-
Applying case definition criteria to irritable bowel syndrome.Clin Med Res. 2008 May;6(1):9-16. doi: 10.3121/cmr.2008.788. Clin Med Res. 2008. PMID: 18591372 Free PMC article. Review.
-
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2020 Oct;5(10):908-917. doi: 10.1016/S2468-1253(20)30217-X. Epub 2020 Jul 20. Lancet Gastroenterol Hepatol. 2020. PMID: 32702295
Cited by
-
Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study.Pain. 2008 Jul;137(1):147-155. doi: 10.1016/j.pain.2007.08.029. Epub 2007 Oct 10. Pain. 2008. PMID: 17928145 Free PMC article.
-
Irritable bowel syndrome: diagnosis and pathogenesis.World J Gastroenterol. 2012 Oct 7;18(37):5151-63. doi: 10.3748/wjg.v18.i37.5151. World J Gastroenterol. 2012. PMID: 23066308 Free PMC article.
-
The burden of IBS: looking at metrics.Curr Gastroenterol Rep. 2009 Aug;11(4):265-9. doi: 10.1007/s11894-009-0039-x. Curr Gastroenterol Rep. 2009. PMID: 19615301 Review.
-
Guidelines on the irritable bowel syndrome: mechanisms and practical management.Gut. 2007 Dec;56(12):1770-98. doi: 10.1136/gut.2007.119446. Epub 2007 May 8. Gut. 2007. PMID: 17488783 Free PMC article. Review.
-
Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.Gut. 2007 Feb;56 Suppl 1(Suppl 1):1-113. doi: 10.1136/gut.2006.117598. Gut. 2007. PMID: 17303614 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources